The 6-min walk test (6MW) as an efficacy endpoint in pulmonary arterial hypertension clinical trials: Demonstration of a ceiling effect-Reference-Cited by-同舟云学术

The 6-min walk test (6MW) as an efficacy endpoint in pulmonary arterial hypertension clinical trials: Demonstration of a ceiling effect

Published:2005-06 Issue:1 Volume:43 Page:36-39
ISSN:1537-1891
Container-title:Vascular Pharmacology
language:en
Short-container-title:Vascular Pharmacology

Author:

Frost Adaani E.,Langleben D.,Oudiz R.,Hill N.,Horn E.,McLaughlin V.,Robbins I.M.,Shapiro S.,Tapson V.F.,Zwicke D.,DeMarco T.,Schilz R.,Rubenfire M.,Barst R.J.

Publisher

Elsevier BV

Subject

Pharmacology,Molecular Medicine,Physiology

Reference8 articles.

1. A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension;Barst;N. Engl. J. Med.,1996

2. Sitaxsentan therapy for pulmonary arterial hypertension;Barst;Am. J. Respir. Crit. Care Med.,2004

3. A means of assessing maximal oxygen intake;Cooper;JAMA,1968

4. Reference equations for the six-minute walk in healthy adults;Enright;Am. J. Respir. Crit. Care Med.,1998

5. Dyspnea, disability and distance walked: comparison of estimates of exercise performance in respiratory disease;McGavin;BMJ,1978

Cited by 149 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical trial design, end-points, and emerging therapies in pulmonary arterial hypertension;European Respiratory Journal;2024-08-29

2. Cardiac effort and 6‐min walk distance correlate with stroke volume measured by cardiac magnetic resonance imaging;Pulmonary Circulation;2024-04

3. Letter by Li et al Regarding Article, “ Streptococcus Species Abundance in the Gut Is Linked to Subclinical Coronary Atherosclerosis in 8973 Participants From the SCAPIS Cohort”;Circulation;2024-01-16

4. Lifestyle Walking Intervention for Patients With Heart Failure With Reduced Ejection Fraction: The WATCHFUL Trial;Circulation;2024-01-16

5. Ralinepag Phase II Open-Label Extension Study in Patients with Pulmonary Arterial Hypertension;Advances in Therapy;2024-01-10